lemme.glp 1 lemme | The first GLP-1 production support supplement of its kind 🧬 Formulated with 3 clinically-studied ingredients, Lemme GLP-1 Daily supports Lemme GLP-1 Daily: Supresa-Based GLP-1

The GLP-1 Receptor Agonist market size reached USD 15.25 Billion in 2024 and is expected to register a revenue CAGR of 21.7%

Plastic containers degrade with repeated heating, releasing compounds that can contribute to digestive discomfort, which is the last thing you need when your GI system is already sensitive from medication

Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov

Backed by Science Cited in 1,500+ scientific publications, Akkermansia muciniphila is recognized as a promising probiotic in reviews from Microbial Biotechnology (PMC6801136), Journal of Applied Microbiology (OUP, 130:6, 1813-1830), Gut Microbes (PMC11364076), and Frontiers in Microbiology (Front Microbiol, 2024) for its role in metabolic health, gut barrier integrity, and immune function

The approval pertains to the GLP-1 drug dubbed Xianweiying also known as ecnoglutide which Pfizer has just acquired in a billion-dollar deal.